UPDATE 2-Dendreon shares plunge, cancer vaccine disappoints
August 04, 2011 at 10:53 AM EDT
Aug 4 (Reuters) - Dendreon Corp shares plunged 64 percent a day after the drugmaker spooked investors with dismal quarterly sales of its cancer vaccine Provenge.